Ergotamine — Discount Pricing
Ergotamine is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Ergotamine Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $125.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Ergotamine
Ergotamine is a prescription medication. Ask your doctor if Ergotamine is right for you.
How to Check Ergotamine Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Ergotamine at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Pain & Inflammation
About Ergotamine
Ergotamine is a powerful medication prescribed to treat acute migraine and cluster headaches. It works by narrowing blood vessels around the brain to reduce migraine symptoms. Unfortunately, many patients face high out-of-pocket costs. TheDrugClub members enjoy significant savings on ergotamine, including $0 co-pays and convenient free home delivery to your door.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Ergotamine is approved for (FDA label)
Ergomar ® is indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or so-called "histaminic cephalalgia".
Source: Read the full FDA label on DailyMed. Label effective date: February 25, 2025.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Boxed warning for Ergotamine (FDA label)
WARNING Serious and/or life-threatening peripheral ischemia has been associated with the coadministration of ergotamine tartrate with potent CYP 3A4 inhibitors including protease inhibitors and macrolide antibiotics. Because CYP 3A4 inhibition elevates the serum levels of ergotamine tartrate, the risk for vasospasm leading to cerebral ischemia and/or ischemia of the extremities is increased. Hence, concomitant use of these medications is contraindicated. (See also CONTRAINDICATIONS and WARNINGS section)
Source: FDA prescribing information (DailyMed). Set ID: a9582fdb-7ddd-4f69-aa7a-66247cdb8c92. SPL document ID: 2ef9fa55-cdc3-dc0a-e063-6394a90a0e5f. Label effective date: February 25, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Ergotamine (FDA label)
Cardiovascular: Vasoconstrictive complications of a serious nature may occur at times. These include ischemia, cyanosis, absence of pulse, cold extremities, gangrene, precordial distress and pain, EKG changes and muscle pains. Although these effects occur most commonly with long-term therapy at relatively high doses, they have also been reported with short-term or normal doses. Other cardiovascular adverse effects include transient tachycardia or bradycardia and hypertension. Gastrointestinal: Nausea and vomiting. Neurological: paresthesias, numbness, weakness, and vertigo. Allergic: Localized edema and itching. Fibrotic Complications: ( See WARNINGS ).
Source: FDA prescribing information (DailyMed). Set ID: a9582fdb-7ddd-4f69-aa7a-66247cdb8c92. SPL document ID: 2ef9fa55-cdc3-dc0a-e063-6394a90a0e5f. Label effective date: February 25, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.